跳至主要内容
临床试验/CTRI/2018/08/015161
CTRI/2018/08/015161尚未招募4 期

Study of efficacy and safety of Intravenous Paracetamol Infusion as intrapartum analgesic: Randomized Control Trial

CRH Sikkim Manipal Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age between 18-35 years.
  • 2.Primigravida and multigravida
  • 3.The gestational age between 37- 42 weeks.
  • 4.Patient seeking analgesia.
  • 5.Single viable fetus.
  • 6.Vertex presentation.
  • 7.1st stage of labour with cervical dilatation 3-4 cm (in active phase).

排除标准

  • 1.Extreme of age (below 18-above 35).
  • 2.Multiple gestation.
  • 3.Malpresentation.
  • 4.Major degree of cephalopelvic disproportion.
  • 5.Any medical disorder with pregnancy e.g., Rheumatic heart disease, Diabetes mellitus, Hypertension.
  • 6.Use of any other kind of analgesia before recruitment in the study
  • 7.Scared uterus.
  • 8.Fetal distress.
  • 9.Antepartum hemorrhage.
  • 10.Polyhydramnios.
  • 11.Intra uterine infections.
  • 12.Hypersensitivity to paracetamol.

研究者

发起方
CRH Sikkim Manipal Institute of Medical Sciences

相似试验